Jessika B Iwanski - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Current Protocols|February 11, 2025

Minimal Component, Protein-Free, and Cost-effective Human Pluripotent Stem Cell Cardiomyocyte DifferentiationJessika B Iwanski, Odunayo S Lawal, William T Kwon, et al.

NPJ Regenerative Medicine|September 16, 2024

Leiomodin 2 neonatal dilated cardiomyopathy mutation results in altered actin gene signatures and cardiomyocyte dysfunctionJessika B Iwanski, Christopher T Pappas, Rachel M Mayfield, et al.

Communications Biology|October 28, 2025

Modelling arrhythmogenic cardiomyopathy fattyfibro pathology with PKP2-deficient epicardial cells derived from human iPSCsSadia L Falana, Sobhi G Kazmouz, Jessika B Iwanski, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Current Protocols|February 11, 2025

Minimal Component, Protein-Free, and Cost-effective Human Pluripotent Stem Cell Cardiomyocyte DifferentiationJessika B Iwanski, Odunayo S Lawal, William T Kwon, et al.

NPJ Regenerative Medicine|September 16, 2024

Leiomodin 2 neonatal dilated cardiomyopathy mutation results in altered actin gene signatures and cardiomyocyte dysfunctionJessika B Iwanski, Christopher T Pappas, Rachel M Mayfield, et al.

Communications Biology|October 28, 2025

Modelling arrhythmogenic cardiomyopathy fattyfibro pathology with PKP2-deficient epicardial cells derived from human iPSCsSadia L Falana, Sobhi G Kazmouz, Jessika B Iwanski, et al.

Pageof 1